Skip to content
HowShorted

Neurogene Inc. short interest in 2026

In 2026, Neurogene Inc.'s disclosed short interest ran from 22.83% of shares outstanding on 15 Jan 2026 to 16.39% on 15 Sep 2026, a change of -6.44 percentage points. The year's high was 25.87% on 31 Mar 2026 and its low 15.18% on 14 Aug 2026, averaging 21.71% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.65 days on 13 Feb 2026. Full history: Neurogene Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Neurogene Inc. in 2026

2026 in figures

Start of year
22.83% (15 Jan 2026)
End of year
16.39% (15 Sep 2026)
Change
-6.44 pp
High
25.87% (31 Mar 2026)
Low
15.18% (14 Aug 2026)
Average
21.71%
Highest days to cover
32.65 (13 Feb 2026)
SEC filings marked
6

Every report in 2026

Neurogene Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202622.83%20.17
30 Jan 202623.18%31.88
13 Feb 202623.27%32.65
27 Feb 202623.72%15.61
13 Mar 202625.08%19.91
31 Mar 202625.87%25.1910-K filed, results (8-K)
15 Apr 202625.76%28.64
30 Apr 202623.89%19.85
15 May 202623.14%24.6510-Q filed, results (8-K)
29 May 202622.77%27.48
15 Jun 202622.78%22.94
30 Jun 202621.52%13.48
15 Jul 202618.80%7.57
31 Jul 202619.30%16.15
14 Aug 202615.18%16.8110-Q filed, results (8-K)
31 Aug 202615.67%13.58
15 Sep 202616.39%16.85

See also: Neurogene Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.